The Directors (together with their families and their family trusts and pension scheme arrangements) in aggregate hold 309,590 ordinary shares in the Company, representing 0.98% of the Company’s current issued share capital.
48.28% of the issued share capital is not in public hands.
The Company is aware of the following significant (3% or greater) shareholdings in the Company’s ordinary shares:
|Number of ordinary shares||% of issued share capital|
|Woodford Investment Management LLP||35.39%|
|Wales Life Sciences Investment Fund LP||9.48%|
The above information was last updated on Friday, 28 September 2018